SCHEMBL5010153

SCHEMBL5010153

[CH2]CC(C)(c1ccccc1)c1cccc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 4/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
KIF11 P52732 1/20 0.40
CYP2D6 P10635 3/20 0.37
HSD17B10 Q99714 2/20 0.37
HIF1A Q16665 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
ACP3 P15309 2/20 0.36
ALDH1A1 P00352 2/20 0.35
CYP2A6 P11509 1/20 0.35
KDM4E B2RXH2 1/20 0.35
NR1I2 O75469 1/20 0.34
LMNA P02545 1/20 0.34
ADRA2A P08913 1/20 0.34
ACHE P22303 1/20 0.34
SLC6A2 P23975 1/20 0.34
HTR2A P28223 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5013836 0.87 CYP2C19 (0.39) CYP2C19CYP3A4TSHRKIF11CYP2D6
SCHEMBL6927504 0.81 KIF11 (0.42) CYP2C19CYP3A4TSHRKIF11CYP2D6
SCHEMBL5240009 0.80 CYP2C19 (0.42) CYP2C19CYP3A4TSHRKIF11CYP2D6
SCHEMBL8804043 0.77 KIF11 (0.38) CYP2C19CYP3A4TSHRKIF11CYP2D6
SCHEMBL4249887 0.77 TAAR1 (0.46) CYP2C19CYP3A4TSHRCYP2D6HIF1A
SCHEMBL5008800 0.77 TSHR (0.40) CYP2C19CYP3A4TSHRKIF11CYP2D6
SCHEMBL28039062 0.76 ALDH1A1 (0.35) CYP2C19TSHRKIF11CYP2D6HSD17B10
SCHEMBL5013862 0.76 TSHR (0.42) CYP2C19CYP3A4TSHRKIF11CYP2D6
SCHEMBL3003485 0.76 CYP3A4 (0.42) CYP2C19CYP3A4TSHRKIF11CYP2D6
SCHEMBL28039341 0.75 ALDH1A1 (0.34) CYP2C19TSHRKIF11CYP2D6HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1962832-A2 COMBINATIONS OF A QUALENE SYNTHASE INHIBITOR AND A HMG-COA REDUCTASE INHIBITOR FOR TREATING HYPERLIPIDEMIA Takeda Pharmaceutical Company Limited (JP) 2008-09-03 EP disclosed
US-20080207864-A1 Organosilanes, Process For Production of the Same, and Use Thereof SHARP KABUSHIKI KAISHA (JP) 2008-08-28 US disclosed
WO-2006129859-A2 COMBINATIONS OF A SQUALENE SYNTHASE INHIBITOR AND A HMG-COA REDUCTASE INHIBITOR FOR TREATING HYPERLIPIDEMIA TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-12-07 WO disclosed